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Summary 
Deterioration of metabolic health is a hallmark of aging and generally assumed to 
be detrimental to longevity. Exposure to a high-calorie diet impairs metabolism 
and accelerates aging; conversely, calorie restriction (CR) prevents age-related 
metabolic diseases and extends lifespan. However, it is unclear whether 
preservation of metabolic health is sufficient to extend lifespan. We utilized a 
genetic mouse model lacking Fabp4/5 that confers protection against metabolic 
diseases and share molecular and lipidomic features with CR to address this 
question. Fabp-deficient mice exhibit extended metabolic healthspan with 
protection against insulin resistance and glucose intolerance, inflammation, 
deterioration of adipose tissue integrity, and fatty liver disease. Surprisingly 
however, Fabp-deficient mice did not exhibit any extension of lifespan. These 
data indicate that extension of metabolic healthspan in the absence of CR can be 
uncoupled from lifespan, indicating the potential for independent drivers of these 
pathways, at least in laboratory mice. 
 
 
 
  
Introduction 
 
Deterioration of metabolic health including emergence of increased adiposity, 
insulin resistance, and dyslipidemia, is a key pathological manifestation of aging 
(Lopez-Otin et al., 2016), and contributes to age-related diseases, such as 
diabetes, cancer, cardiovascular disease, and neurodegenerative diseases. In 
the past two decades, much has been learned about the etiology and underlying 
mechanisms of the decline in metabolic health (Hotamisligil, 2017; Shulman, 
2014). For example, metabolically driven chronic inflammation or 
metaflammation, ectopic fat deposition and metabolism, and organelle 
dysfunction all contribute to insulin resistance and abnormal glucose 
homeostasis. Metabolic stress associated with hyperlipidemia engages key 
inflammatory and stress signaling modules, including c-Jun N-terminal kinase 
(JNK), inhibitor of nuclear factor kappa-B kinase (IKK) and protein kinase C 
(PKC), interferes with metabolic physiology orchestrated by nutrient-sensing 
pathways, e.g. insulin signaling, adenine-monophosphate-activated protein 
kinase (AMPK), and mammalian target of rapamycin (mTOR), and ultimately 
leads to metabolic dysfunction and disease (Arruda and Hotamisligil, 2015; 
Hotamisligil, 2006). Dietary restriction regimens, prominently calorie restriction, 
on the other hand, delay the onset of aging and age-associated diseases and 
impact the aforementioned mechanisms in a corrective manner (Anderson and 
Weindruch, 2010; Fontana et al., 2010; Yang et al., 2016). In fact, mounting 
studies targeting these inflammatory modules and nutrient-sensing pathways 
lend support to the concept that increasing metabolic fitness may extend 
healthspan and lifespan across the phyla. 
 
As demonstrated in the early genetic studies in round worms and flies, the 
mechanisms linking metabolic health and aging are finely controlled and context-
dependent (Kenyon, 2010). For example, while blunting insulin/insulin-like growth 
factor (IGF) signaling extends lifespan, total ablation of this pathway is 
detrimental to metabolic health and even longevity (Accili et al., 1996; Joshi et 
al., 1996). Holzenberger et al. report that heterozygous knockout of IGF receptor 
increases the lifespan in female mice by 33%, but does not alter the lifespan of 
males, possibly due to severely impaired glucose tolerance (Holzenberger et al., 
2003). Our group has shown that in mice, obesity-induced JNK activation 
suppresses insulin signaling and impairs metabolic health (Hirosumi et al., 2002), 
however, studies in fruit flies suggest that hyperactivation of JNK can increase 
lifespan by tuning down insulin signaling (Wang et al., 2005). These observations 
call into the question the direction and nature of the relationship between 
metabolic health and lifespan, and how nutrients and their metabolism regulate 
the action of these pathways (Hansen et al., 2013).  
 
Fatty acid binding proteins (FABPs) are known as intracellular buffer proteins for 
fatty acids that are involved in lipid trafficking, metabolism, and signaling 
(Hotamisligil and Bernlohr, 2015). Of the nine FABP isoforms in mammals, 
FABP4 and FABP5 (also known as aP2 and mal1, respectively) carry out 
important immunometabolic functions and are the best-characterized mediators 
of metabolic diseases (Furuhashi and Hotamisligil, 2008; Hotamisligil and 
Bernlohr, 2015). The roles of Fabp4/5 in the pathogenesis of metabolic diseases 
appear to be mainly due to their functions in adipocytes and macrophages, 
although they are expressed more broadly (Furuhashi et al., 2008) and can also 
act as hormones through their secreted forms (Burak et al., 2015; Cao et al., 
2013). Considering the redundancy of their lipid trafficking function and molecular 
compensation, these two genes have been studied in a double knockout mouse 
model (Maeda et al., 2005). Combined deficiency of Fabp4 and Fabp5 (hereafter 
referred to as Fabp-deficient) protects mice from high fat diet (HFD)-induced 
obesity, hepatic steatosis, insulin resistance and diabetes (Maeda et al., 2005). 
In the leptin-deficient mouse model, Fabp-deficiency restores euglycemia and 
improves glucose tolerance and insulin sensitivity, despite severe obesity (Cao et 
al., 2006). Fabp-deficiency also protects against atherosclerosis and extends 
survival in apolipoprotein E-deficient mice (Boord et al., 2004). Thus the Fabp-
deficient mice provide a useful model to address the question whether 
preservation of metabolic health contributes to extension of lifespan. 
 
Here, we examined metabolic function in multiple cohorts of Fabp-deficient mice 
in independent facilities. Collectively, our results show that Fabp-deficiency 
remarkably attenuated age-related body weight gain and deterioration of glucose 
tolerance, insulin sensitivity, hepatosteatosis and abnormalities of tissue 
structure in female mice, with smaller effects observed in male mice. Lipidomic 
and gene expression profiling of adipose tissue revealed a remarkable similarity 
between the effects of Fabp-deficiency and calorie restriction (CR), and CR also 
decreased the level of circulating FABP4. However, examination of the lifespan 
and healthspan of Fabp-deficient mice of both sexes did not reveal any alteration 
of lifespan or preservation of muscular, cognitive, or cardiac functions with age. 
In summary, these results indicate that even a marked extension of metabolic 
healthspan does not necessarily lead to extension of the lifespan or the 
preservation of cardiac, muscular, and cognitive systems, at least in laboratory 
mice. 
 
  
Results  
 
Fabp-deficiency protects against age-related weight gain and glucose intolerance 
 
Weight gain during aging can contribute to the decline of insulin sensitivity and 
glucose tolerance and can contribute to the development of metabolic diseases 
(Longo et al., 2015). Given that Fabp4/5 deficiency protects against diet-induced 
obesity, insulin resistance, and diabetes in young mice, we asked whether it 
might also confer these benefits in aging mice in the absence of a dietary 
challenge. To this end, we evaluated the metabolic health of middle-aged (11-12 
months) Fabp-deficient and control mice of both sexes, maintained throughout 
their life on regular chow diet. In both males and females, Fabp-deficiency 
reduced body weight gain (female WT 37.2 ± 1.74 g, Fabp4/5-/- 29.4 ± 0.965 g, P 
< 0.01; male WT 46.2 ± 2.54 g, Fabp4/5-/- 38.9 ± 1.98 g, P < 0.05, Student’s t-
test) (Figure 1A). In line with decreased adiposity (Figure 1A), female Fabp-
deficient mice also displayed decreased circulating levels of leptin (Figure 1B). 
Male Fabp-deficient mice exhibited decreased circulating leptin, despite no 
statistically significant change in fat mass. Furthermore, Fabp-deficiency 
improved glucose tolerance in middle-aged mice in both sexes (Figure 1C), 
associated with improved insulin sensitivity (Supplementary Figure 1A). In a 
second cohort, similar improvements in body weight were observed in Fabp-
deficient mice analyzed at 15 months of age of both sexes (Supplementary 
Figure 1B). Improvements in systemic glucose metabolism were stronger in 
female Fabp-deficient mice (Supplementary Figure 1C). These results indicate 
that the metabolic protection is a robust and persistent phenotype with more 
marked effects in female mice.  
 
In light of the pathogenic roles of Fabp4 and Fabp5 in diet-induced obesity, we 
next challenged a cohort of late-middle-aged mice (15 month-old, N = 10 per 
group of each sex) with a high fat diet for additional 8 months. This regimen is 
known to provoke additional metabolic stress and further exacerbate insulin 
resistance and impaired glucose metabolism. Consistent with the metabolic 
protection observed in chow-fed mice, aged high-fat diet-fed Fabp4/5-/- mice also 
exhibited improved systemic glucose intolerance (Figure 1D). Although the 
insulin sensitizing effect of Fabp deficiency in this setting was very marked in 
females, it did not reach statistical significance in males. However, euglycemia 
was maintained in Fabp4/5-/- mice in both sexes at the end of this regimen 
(Supplementary Figure 1D). These data provide strong evidence of the critical 
role for Fabp4 and Fabp5 in the deterioration of metabolic health in the setting of 
both aging and diet-induced obesity.  
 
Fabp4/5 deficiency protects against age-related pathologies in metabolic tissues 
 
We next performed histological analysis of liver, brown adipose tissue (BAT), and 
white adipose tissue (WAT). Ectopic fat accumulation and adipose tissue 
inflammation are known measures of age-associated pathology (Gregg et al., 
2012; Sellayah and Sikder, 2014; Woods et al., 2012). Consistent with the 
observed improvement in metabolic health, Fabp-deficiency abrogated 
hepatosteatosis in both sexes (Figure 2A). The ultra-structure of livers from aged 
mice showed that Fabp4/5 deficiency preserved the integrity of endoplasmic 
reticulum (ER) and mitochondria, with sparse formation of glycogen granules and 
lipid droplets (Figure 2B). In addition, Fabp-deficiency markedly alleviated the 
age-related lipid-laden status of brown adipose tissue (Figure 2C), and mitigated 
inflammation indicated by the dramatically reduced formation of crown-like 
structures in WAT (Figure 2D).  
 
We also found that female Fabp-deficient mice exhibited significantly decreased 
circulating levels of proinflammatory cytokines interleukin-6 (IL-6) 
(Supplementary Figure 2A) and tumor necrosis factor alpha (TNF) 
(Supplementary Figure 2B). However, the level of these pro-inflammatory 
molecules in serum was not mitigated in the same manner in male Fabp-deficient 
mice. Furthermore, the improved brown fat structure was associated with 
increased energy expenditure in middle-aged mice (Supplementary Figure 2C), 
despite no significant difference in food intake (Supplementary Figure 2D). In 
addition to regulation of the resting energy expenditure, Fabp-deficiency 
increased respiratory exchange ratio in male mice, reflecting a shifted fuel 
preference from lipids to carbohydrates  (Supplementary Figure 2E). These data 
demonstrate that Fabp-deficiency confers protection against age-associated 
pathologies of metabolic organs, although there are sex-related differences in the 
extent of these effects. 
 
Caloric restriction mimics adipose tissue lipidome changes observed in Fabp- 
deficiency 
 
We reasoned that if Fabp4 and Fabp5 actions are involved in the age-related 
deterioration of metabolic systems, Fabp signaling pathways may also be 
antagonized by calorie restriction, which is a well-established modulator of health 
and life span. To test this hypothesis, we first examined the impact of short-term 
CR on circulating levels of FABP4 and FABP5 and adipose tissue de novo 
lipogenesis, an outcome closely linked to Fabp-deficiency (Cao et al., 2008). 
C57BL/6 male mice were fed 40% calorie restricted diet (CR) or regular chow (ad 
libitum, AL) for 4 weeks. We observed that this regimen was associated with 
decreased serum FABP4 (Figure 3A) (AL 102.9 ± 13.95 ng/mL, CR 36.25 ± 
9.789 ng/mL, n = 5), without altering FABP5 (Figure 3A). This was not due to a 
reduction in secretion from adipose tissue as we observed increased secretion of 
FABP4 (2.6 ± 0.5 fold) and FABP5 (3.4 ± 0.3 fold) from adipose tissue explants 
isolated from CR male mice (Supplementary Figure 3A Upper Panel). Therefore, 
the reduction in circulating FABP4 observed in CR mice may be a reflection of 
decreased total adiposity or perhaps decreased secretion from a non-adipose 
source of FABP4. The CR-induced FABP4 secretion may also be sex dependent, 
as we did not observe any significant change in CR female mice (Supplementary 
Figure 3A Lower Panel). Conversely, CR increased the expression of Fabp5 in 
adipose tissue without altering Fabp4 (Figure 3B and Supplementary Figure 3B-
C).  
 
De novo lipogenesis (DNL) is a key mechanism linking adipose tissue to 
systemic metabolism, and adipose tissue DNL is elevated in Fabp-deficient mice 
(Cao et al., 2008; Yore et al., 2014). Western blot analysis of adipose tissue 
revealed that CR increased levels of key enzymes in the DNL pathway, including 
acetyl-CoA carboxylase (ACC), ATP-citrate lyase (ACLY), and acetyl-CoA 
synthetase 2 (ACAS2) (Figure 3B and Supplementary Figure 3B-C). Together 
with results of the FABP4 secretion assay, these findings suggest that secreted 
FABP4 may not be critical for regulation of DNL in adipose tissue during CR. 
Next, we explored the transcriptional mechanism of elevated DNL in CR. We 
found that short-term CR increased the level of the cleaved form of sterol 
regulatory element-binding protein 1c (SREBP1C) in adipose tissue, indicative of 
increased SREBP1C activity (Supplementary Figure 3D). Though carbohydrate 
responsive element-binding protein (ChREBP) was readily detectable in liver, we 
did not detect ChREBP protein in adipose tissue in either dietary regimen. In 
contrast, we did not observe increased SREBP1C cleavage in the adipose tissue 
from young Fabp-deficient mice (Supplementary Figure 3E), suggesting an 
alternative activation of lipogenic pathway in this model. Together, these results 
suggest that short-term calorie restriction antagonizes important Fabp-regulated 
pathways. 
 
Next, we examined whether long-term calorie restriction regulates the lipidome of 
adipose tissue in a pattern reminiscent of Fabp-deficiency by profiling lipids in 
WAT and liver in a systematic manner. Tissue samples were collected from 19-
month-old C57BL/6 male mice that had been fed a 40% calorie restricted diet 
(60% of calories consumed by ad libitum fed mice) since the age of 16 weeks, or 
from 20-month-old ad libitum control mice. We then compared these lipid profiles 
to those of 20-week-old C57BL/6 WT and Fabp-deficient mice from a previous 
study (Cao et al., 2008) in a side-by-side manner. Similar to Fabp4/5 deficiency, 
CR increased the level of non-esterified fatty acids (NEFA) in WAT (Figure 3C). 
Palmitoleate (C16:1n7) levels are low in diet and thus its serum level serves as a 
marker for endogenous de novo synthesis of fatty acids, in this case derived from 
adipose tissue (Cao et al., 2008). We have previously shown that adipose tissue 
production of palmitoleate is enhanced in Fabp4/5 deficiency, and furthermore, 
that exogenous palmitoleate infusion is sufficient to improve insulin sensitivity in 
mice (Cao et al., 2008). Here, we found that CR resulted in a 3-fold increase in 
palmitoleate in WAT, similar to the degree of change observed in Fabp4/5 
deficiency (Figure 3D). To our knowledge, this is the only example of a 
physiological stimulus that so robustly induces adipose tissue DNL and 
palmitoleate production (Bruss et al., 2010). In mammalian cells, newly 
synthesized fatty acids are mainly shunted for biosynthesis of diacylglycerol 
(DAG) and phospholipids (Berg, 2002). Consistent with our observation of 
increased accumulation of NEFAs, both CR and Fabp-deficiency increased 
levels of DAG and phospholipids in WAT (Figure 3E and Supplementary Figure 
3F). Interestingly, however, CR also induced decreases in the levels of NEFAs, 
palmitoleate, and DAGs in the liver, changes that were not observed in Fabp-
deficiency (Figure 3C-E).  
 
Just as short-term CR increased the capacity of adipose tissue de novo 
lipogenesis (DNL) (Figure 3B), transcript profiling of adipose tissue showed that 
long-term CR induced more than 100-fold the expression levels of key DNL 
enzymes, e.g. Acly, Acas2, and Acc (Figure 3F), and in fact increased the 
transcript levels of every enzyme in the DNL pathway (Figure 3G). It has 
previously been reported that aging decreases the transcript levels of adipogenic 
genes (e.g. Fasn and Acc) in rat adipose tissue, which can be restored by CR 
(Linford et al., 2007). To understand these data in the context of aging, we 
performed computational analysis of this published dataset (NCBI GEO 
accession ID: GSE6718), and found that the transcriptional program for adipose 
tissue DNL was suppressed in aging, but was restored by CR (Figure 3H), which 
strongly supports the concept that adipose tissue DNL is transcriptionally 
regulated during aging and anti-aging interventions. Overall, our systematic 
approach verified that long-term CR induces a transcriptional program of DNL in 
adipose tissue, contributing to a lipid profile that resembles Fabp4/5 deficiency.   
 
Fabp4/5 deficiency does not extend lifespan  
 
Given the connections between metabolic health and longevity, we next asked 
whether Fabp4/5 deficiency increases lifespan. Interestingly, we observed that 
there was no significant difference between the survival curves of Fabp-deficient 
and control mice of either sex (Figure 4A). This study was carried out in the 
Harvard TH Chan School of Public Health (HSPH) animal facility. The absence of 
an effect on lifespan was also independently reproduced at the San Antonio 
Nathan Shock Center (UT Health San Antonio) with mice bred at our institution 
(data not shown). Despite unaltered lifespan, middle-aged Fabp-deficient mice 
displayed a qualitatively younger-looking general physical appearance, as shown 
in the photographs (Figure 4B). In agreement with no change in lifespan, serum 
insulin-like growth factor (IGF-1) was not different between middle-aged Fabp4/5-
/- and WT mice (Supplementary Figure 4A). A potential impact of Fabp-deficiency 
on life span was also evaluated on mice that were subjected to HFD. Similar to 
animals of standard diet and, despite the profound resistance to diet-induced 
metabolic decline in aged mice (Figure 1E), Fabp deficiency did not alter survival 
of mice on the HFD feeding regimen (Supplementary Figure 4B).  Hence, 
multiple studies in independent facilities and cohorts of mice all demonstrated 
identical life span between wild type and Fabp-deficient animals.  
 
To investigate the effect of Fabp deficiency on the aging of other physiological 
systems, we performed further healthspan studies in aged (30-month-old) mice, 
including assessments of cardiac, muscular, and cognitive functions. 
Surprisingly, Fabp4/5-deficient mice of either sex did not exhibit a significant 
improvement on measures of cardiac function (Figure 4C-E). Echocardiography 
revealed potentially decreased heart function in aged female Fabp4/5-/- mice but 
not in male mice. Specifically, Fabp deficiency decreased body weight-adjusted 
left ventricle mass and end diastolic dimension in females, indicative of left 
ventricle atrophy, although ejection fraction was not significantly altered. Fabp-
deficiency did not improve measures of muscular function, such as grip strength 
(Figure 4F), and gait characteristics (Supplementary Tables 1-2) in mice of either 
sex. Instead, we observed decreased grip strength in Fabp-deficient female 
mice, although this parameter was unaltered in males, indicating the potential of 
a sex-specific decrease in neuromuscular function associated with Fabp4/5 
deficiency. Fabp-deficiency also did not result in significant improvements in 
measures of cognitive function, such as Y-maze test assessing learning and 
working memory (Supplementary Figure 4C), or the tail suspension test 
assessing anti-depressant activity (Supplementary Figure 4D). Together, these 
studies suggest that despite broad metabolic improvement, Fabp deficiency does 
not extend lifespan or promote the maintenance of cardiac, muscular, or 
cognitive systems. 
 
Discussion 
 
In this study, we have shown that the lipid chaperones FABP4/5 are critical 
intermediate factors in the deterioration of metabolic systems during aging. 
Consistent with their roles in chronic inflammation and insulin resistance in young 
prediabetic mice, we found that FABPs promote the deterioration of glucose 
homeostasis, metabolic tissue pathologies, particularly in white and brown 
adipose tissue and liver, and local and systemic inflammation associated with 
aging. A systematic approach, including lipidomics and pathway-focused 
transcript analysis, revealed that caloric restriction and Fabp4/5 deficiency result 
in similar changes to the adipose tissue metabolic state, specifically enhanced 
expression of genes driving de novo lipogenesis and NEFA accumulation. 
Furthermore, caloric restriction was associated with reduced FABP4 in circulation, 
providing a potential molecular mechanism underlying its metabolic benefit.  
 
The extension of metabolic health by Fabp-deficiency is long-lasting even in 
aged female mice and even after a high fat diet challenge (Figure 1E). We 
noticed sexual dimorphism in adiposity (Figure 1A), FABP4 secretion in response 
to CR (Supplementary Figure 3A), glycemic control at late ages (Figure 1D, and 
Supplementary Figure 1C), systemic inflammation (Supplementary Figure 2A-B), 
and cardiomuscular functions (Figure 4C-F), suggesting that sex-related factors 
may impact these phenotypes in the context of aging. Interestingly, we did not 
observe a reduction in the secretory capacity for FABP4 in adipose tissue during 
CR, suggesting that the reduction seen in serum levels may reflect overall 
adiposity or point to the possibility of an alternate source of secreted FABP4. 
However, despite the remarkable protection in glycemic control, insulin sensitivity, 
inflammation, and tissue steatosis in Fabp-deficient mice, we did not observe any 
change in the life span curves. We also did not detect preservation of cardiac, 
muscular, and cognitive functions. In females, there was even a mild decline in 
cardiomuscular function associated with Fabp-deficiency during aging. These 
observations support the concept that in higher organisms significant 
improvements in metabolic tissue inflammation, metabolic tissue integrity, and 
systemic metabolic homeostasis may not necessarily lead to increased longevity.  
 
Interestingly, previous studies have suggested a link between the maintenance of 
glucose homeostasis and overall health in aging. For example, epidemiology and 
clinical trials in type 1 diabetic patients gave rise to the concept that tight 
glycemic control extends both health span and lifespan in patients (Rodriguez-
Gutierrez and Montori, 2016). Metformin, a commonly prescribed drug for type 2 
diabetes, increases lifespan and healthspan of male mice (Martin-Montalvo et al., 
2013). However, emerging evidence from the Action to Control Cardiovascular 
Risk in Diabetes (ACCORD) trial has challenged this conclusion and found that 
intensive glycemic control had neutral effects on death and nonfatal 
cardiovascular events among persons with advanced type 2 diabetes, and may 
paradoxically increase cardiovascular-related death (Accord_Study_Group, 2016; 
Accord_Study_Group et al., 2011). Recent studies suggest that calorie restriction 
also extends lifespan in a context-dependent manner, though it uniformly 
improves metabolic health (Mattison et al., 2012; Mitchell et al., 2016; Pearson et 
al., 2008). Further supporting the concept that these endpoints can be uncoupled, 
exercise improves metabolic health, but does not uniformly increase lifespan in 
mice (Samorajski et al., 1985), and genetic studies targeting insulin/IGF or 
mTORC1 pathways suggest that extension of lifespan does not necessarily 
require the maintenance of glucose homeostasis (Lamming et al., 2012; Selman 
et al., 2008). Although these studies do not establish causality, it may also be the 
case in humans that metabolic health does not lead to longevity but to a 
sustained health span.  
 
To our knowledge, our studies with Fabp-deficient mice constitute the first 
genetic evidence in animal models that prolonged metabolic health, particularly 
glucose and lipid homeostasis, may be uncoupled from lifespan and 
maintenance of cardiac, muscular, and cognitive systems, which partially 
recapitulates the human pathophysiology observed during intensive glycemic 
control. Furthermore, it is intriguing that there is a considerable overlap between 
the unique lipidomic profile, especially in adipose tissue, of Fabp-deficient 
animals with those that have been subject to caloric restriction.  Future studies 
exploring the similarities and distinctions between these models in multiple sites 
may provide additional insights into specific pathways and their regulation of 
healthspan and lifespan.  Further exploration of the disconnect between 
metabolic health and longevity may also shed light on alternative therapeutic 
approaches against diabetes and possibly other metabolic diseases that are 
associated with aging as a risk factor.  
 
 
Experimental Procedures 
 
Use and Treatment of Animals 
Mice were produced and housed in a specific pathogen-free barrier facility 
certified by Association for Assessment and Accreditation of Laboratory Animal 
Care (AAALAC). All procedures were approved by the Harvard Medical Area 
(HMA) Institutional Animal Care and Use Committees (IACUC) and the University 
of Texas Health Science Center at San Antonio (UTHSCSA) IACUC. Long-term 
calorie restriction: C57BL/6 male mice (n = 6) were housed individually, and fed 
on a calorie restricted (CR) chow (NIH31/NIA fortified 3.0 g pellets), or ad libitum 
(AL) chow (NIH31random weight chunk formula) before euthanization at the age 
of 19 months or 20 months. CR was initiated at 14 weeks of age at 10%, then 15 
weeks of age at 25%, and finally at 16 weeks of age at 40%. Mice were 
euthanized after a 5-hour food withdrawal at 03:30 PM. Short-term calorie 
restriction: C57BL/6 male/female mice (n = 3 or 6) were housed individually, and 
fed on a 40% CR chow for 3.5-4 weeks as indicated, or ad libitum (AL) chow.  
Lifespan studies: Virgin C57BL/6 mice, i.e. Fabp4/5-/- and wild-type (WT) 
littermates, were generated from breeder pairs carrying heterozygous alleles for 
Fabps. Upon weaning, 80 mice of the same sex but different genotypes were 
housed together at a density of 3-4 mice/cage, and allowed to live out their 
normal lifespan. An independent lifespan study was carried out in UTHSCSA 
Barshop Institute for Longevity and Aging Studies. Mice with homozygous null 
mutations in Fabp4 and Fabp5, and WT littermates (N = 30 per genotype for 
females; N = 29 male WT, and N = 31 male Fabp4/5-/-) were generated in the 
Harvard TH Chan School of Public Health animal facility and shipped to 
UTHSCSA. Healthspan studies: The healthspan of mice was assessed in 
Healthspan and Functional Assessment Core of the San Antonio Nathan Shock 
Center (http://nathanshock.barshop.uthscsa.edu/healthspan-and-functional-
assessment/), with mice bred at Harvard as described above (Details can be 
found in the section Lifespan studies). Metabolic studies: Cohorts of Fabp4/5-/-
and littermate WT mice at the age of 11-12 months or 15-16 months were used 
for metabolic studies, including metabolic phenotyping studies, gross pathology 
and microscopic analysis of tissues. These experiments were performed at the 
animal facility of Harvard T.H. Chan School of Public Health. Metabolic cage 
(Oxymax, Columbus Instruments) and total body fat measurement by DEXA 
(PIXImus) were performed as previously described (Furuhashi et al., 2007). 
Glucose tolerance tests were performed by intra peritoneal injection of glucose at 
a dose of 1.0 g/kg after a 16-hour overnight fast. Insulin tolerance tests were 
performed by intraperitoneal injection of insulin at a dose of 1 U/kg after a 6-hour 
daytime food withdrawal. Glucose levels were read using Breeze2 glucose test 
strips (Bayer). 
 
Statistical and Demographic Analysis 
Data are presented as mean ± SEM. N indicates the number of animals per test 
group. Data passed the Shapiro-Wilk normality test. Student’s t-test (unpaired, 
two-tailed, equal variance) and post-hoc Sidak test were used for comparisons. 
P-values are shown in the figures. N.S., not significant, * P < 0.05, ** P < 0.01, 
*** P < 0.01, **** P < 0.0001. Data from global lipid profiling were processed in 
Prism 6 (GraphPad Software), and analyzed by Holm-Sidak-adjusted t tests. 
Demographic data were processed in Prism 6, and analyzed by Kaplan-Meier 
method and log-rank test.  
 
Biomarker assays and ELISA 
Serum samples were subjected to Meso Scale Discovery Assay System (MSD 
#K152BYC and K15012C) for quantification of leptin, TNF, and IL-6. Serum IGF-
1 levels were measured by Mouse/Rat IGF-1 Quantikine ELISA Kit (R&D 
Systems, #MG100). Serum FABP5 levels were measured by CircuLex Mouse 
FABP5/E-FABP/mal1 ELISA Kit (MBL CircuLex cat# CY-8056). Serum FABP4 
levels were measured by an in-house developed aP2 sandwich ELISA system. 
FABP4 antibodies (Clone G9 and HA3) recognizing different epitopes were 
produced at Dana-Farber Cancer Institute Antibody Core Facility, and used as 
the capture antibody and detection antibody, respectively (Burak et al., 2015). 
After an overnight coating by 10 μg/mL Clone G9, a 96-well high-bind microplate 
(Corning 2592) was washed three times by 0.1% Tween-20 PBS, blocked by 5% 
BSA-PBS for 1 h, and incubated with 10 times diluted serum samples for 1 h. 
After 3 times wash, the plate was incubated with 200 ng/mL HRP-conjugated 
Clone HA3 antibody for 1 h. After 6 times wash, TMB buffer was added to the 
plate for color development and 0.18 M H2SO4 was added to terminate the 
reaction. Mouse A-FABP standard protein was obtained from Biovendor. The 
absorbance was read at 450 nm. 
 
Histology and Electron Microscopy 
Paraffin-embedded specimens were stained with H&E. Olympus CX41 
microscope linked to a CCD camera was used to image H&E stained slides. 
Pathological scores were graded in a blinded fashion. For transmission electron 
microscopy: 2-year-old WT and Fabp4/5-/- female mice were anesthetized with 2 
mg/ml xylazine and 2 mg/ml ketamine and perfused with saline followed by 
fixative buffer containing: 2.5% glutaraldehyde, 2.5% paraformaldehyde in 0.1 M 
sodium cacodylate buffer (pH 7.4). After perfusion, small pieces (1-2 mm cubes) 
of liver were immersed in the same fixative buffer described above for at least 2 
hours at 4 oC. The tissues were washed in 0.1M cacodylate buffer and post-fixed 
with 1% osmiumtetroxide (OsO4)/1.5% potassiumferrocyanide (K4Fe(CN)6) for 1 
hr, washed in water three times and incubated in 1% uranyl acetate in maleate 
buffer for 1 hr followed by a three-time wash in maleate buffer and subsequent 
dehydration in grades of alcohol (10 min each; 50%, 70%, 90%, 2x10 min 100%). 
The following day, samples were embedded in TAAB 812 Resin mixture and 
polymerized at 60 oC for 48 hrs. After embedding, ultra-thin sections (about 90 
nm) were generated using a Reichert Ultracut-S microtome, collected on to 
copper grids, stained with lead citrate and examined in a JEOL 1200EX - 80kV 
microscope. Images were recorded with an AMT 2k CCD camera at 4000x 
magnification. 
 
Western Blot Analysis 
Proteins were extracted from adipose tissue or liver samples with NP-40 lysis 
buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 1 mM EDTA, 10 
mM NaF, 2 mM Na3VO4, PMSF) with complete protease inhibitors (Sigma-
Aldrich) and subjected to 4-12% gradient SDS-polyacrylamide gel 
electrophoresis (NuPAGE™ Novex™ 4-12% Bis-Tris Protein Gels, 
ThermoFisher). Proteins from PAGE gels were transferred to PVDF membranes. 
Membranes were blotted for FABP5 (Cell Signaling #39926, 1:1000), FABP4 (in-
house, clone HA3 (Burak et al., 2015) HRP conjugated, 1:10,000; or Proteintech 
#12802-1-AP, 1:5,000 in FABP secretion assay), ACC (Cell Signaling #3662, 
1:1000; or #3676, 1:5,000 in adipose explant analysis), ACLY (Cell Signaling 
#4332, 1:1000, or 1:5,000 in adipose explant analysis), ACAS2 (Cell Signaling 
#3658, 1:5,000), SREBP1 (Santa Cruz, clone K-10, sc-367, 1:500), ChREBP 
(Santa Cruz, clone M-300, sc-33764, 1:500), GAPDH (Bioeasytech #BE0023, 
1:5,000), HSP70 (Proteintech, #10995-1-AP, 1:5,000), and beta-Tubulin (Santa 
Cruz, sc-9104, 1:1000). 
 
FABP Secretion Assay 
Subcutaneous adipose depots were dissected for explant culture (subcutaneous 
depots were used because the size is comparable between CR and AL mice). 
Adipose tissue samples (one lobe per mouse) were washed in high-glucose 
pyruvate-supplemented DMEM (hereafter referred to as DMEM) twice and 
DMEM containing 10% FBS consecutively and minced into roughly 2 mm-size 
pieces with scissors. Explants were washed with DMEM with 10% FBS and 
incubated for 1 h in 500 μL DMEM with 10% FBS. Conditioned medium (CM) 
sample was prepared by mixing 100 μL CM with 20 μL 6X Laemmli’s buffer. Cell 
lysate (CL) sample was prepared by homogenizing explant in 1 mL lysis buffer, 
centrifuged at 12,000 rpm at 4 oC for 10 minutes, and mixing 100 μL CL with 20 
μL 6X Laemmli’s buffer. Protein samples were denatured at 70 oC for 5 minutes 
and analyzed by Western blot analysis. 
 
Quantitative Real-time RT-PCR  
Total RNA was isolated using Trizol Reagent (Invitrogen) and cDNA was 
synthesized with iScript Reverse Transcription Supermix (Bio-Rad). Quantitative 
real-time PCR analysis was performed using Power SYBR Green Master Mix 
(Thermo-Fisher) in ViiA 7 Real-Time PCR systems (Applied Biosystems). Data 
were normalized to acidic ribosomal phosphoprotein P0 (Rplp0, 36B4) 
expression. The primer sequences are listed in Table S3. 
 
Systematic Analysis of Lipid Profiles  
Lipids from tissues were determined by TrueMass Profiling—TrueMass Lipomic 
Panel (Lipomics Technologies, West Sacramento, CA). Specifically, lipids were 
extracted from tissues in the presence of authentic internal standards by the 
Folch method with chloroform:methanol (2:1 v/v). Individual lipid classes were 
separated by liquid chromatography. (Agilent Technologies model 1100 Series). 
Each lipid class was transesterified in 1% sulfuric acid in methanol under a 
nitrogen atmosphere at 100 oC for 45 min. The resulting fatty acid methyl esters 
were extracted from the mixture with hexane containing 0.05% butylated 
hydroxytoluene and prepared for gas chromatography under nitrogen. Fatty acid 
methyl esters were separated and quantified by capillary gas chromatography 
(Agilent Technologies model 6890) equipped with a 30 m DB-88MS capillary 
column (Agilent Technologies) and a flame-ionization detector. Global lipid 
profiles from 4-month-old wildtype and Fabp4/5-/- deficient mice were previously 
reported (Cao et al., 2008), and were plotted in this study for the purpose of side-
by-side comparison. 
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Figure Legends 
 
Figure 1. Fabp-deficiency protects against age-related weight gain and 
decline in glucose homeostasis. Middle-aged (11~12-month old) mice of both 
sexes were investigated for metabolic phenotypes (N = 7-8 female, N = 6 male). 
A. Body weight and body composition measured by DEXA. B. Circulating levels 
of leptin (N = 5-6). C. Intraperitoneal glucose tolerance test (IPGTT). Open circle, 
WT; closed circle, Fabp4/5-/-. Areas under the curve (AUC) were plotted on the 
right. D. Homeostatic model assessment of insulin resistance (HOMA-IR) in aged 
(23-month-old and 8-month-HFD-fed) mice (N = 3 per group). Data were 
presented as mean ± SEM, and analyzed by unpaired two-way Student’s t-Test 
or two-way ANOVA post hoc Sidak test, *P < 0.05, **P < 0.01, ***P < 0.001. See 
also Figure S1. 
 
Figure 2. Fabp deficiency protects against age-related pathologies in 
metabolic tissues. Histological analysis of middle-aged (12-month old) mice (N 
= 6 per gender per genotype, except N = 4 for Fabp4/5-/- female mice). A. 
Histology and pathology grades of liver. Scale bar, 50 μm. Grade 0, normal; 
Grade 1, microvesicular steatosis; Grade 2, macrovesicular steatosis. B. 
Representative transmission electron microscopy (TEM) of liver sections from 2-
year-old WT and Fabp4/5-/- mice. GG (glycogen granules), ER (endoplasmic 
reticulum), M (mitochondria), LD (lipid droplet). C. Histology and pathology 
grades of brown adipose tissue (BAT). Scale bar, 50 μm. Grade 0, normal; 
Grade 1, multilocular and sparse unilocular lipid droplets; Grade 2, multilocular 
and dense unilocular lipid droplets; Grade 3, unilocular lipid droplets. D. Histology 
and pathology grades of white adipose tissue (WAT). Scale bar, 100 μm. Grade 
0, normal; Grade 1, sparse crown-like structures; Grade 2, large or multiple 
crown-like structures. See also Figure S2. 
 
Figure 3. Caloric restriction mimics adipose tissue lipidome changes 
observed in Fabp deficiency. A. Circulating levels of FABP4 and FABP5 in 4-
week CR mice and ad libitum control mice (N = 5). B. Western blot analysis of 
subcutaneous adipose tissue from 4-week CR mice and ad libitum control mice 
(N = 3). (C-G) Epididymal white adipose tissue (WAT) and liver samples from 20-
month-old calorie restricted (CR Aged), ad libitum (AL Aged) control mice, 4-
month-old wildtype (WT Young) and Fabp4/5 deficient (Fabp4/5-/- Young) mice 
were subjected to lipidomics analysis (N = 6). Levels of non-esterified fatty acids 
(C), C16:1n7 palmitoleate (D), diacylglycerols (E). F. Expression of genes 
involved in adipose tissue DNL. G. Illustration of the de novo lipogenesis 
pathway. Enzymes (blue) and fold change (CR/AL, red) of mRNAs are marked.  
H. Transcript levels of DNL enzymes in rat adipose tissue (N = 5-7). Data were 
retrieved from a previous microarray profiling study (Linford et al. 2007). Data 
were presented as mean ± SEM, and analyzed by unpaired two-way Student’s t-
Test, *P < 0.05, **P < 0.01, ***P < 0.001. See also Figure S3. 
 
Figure 4. Fabp deficiency does not extend lifespan. A. Kaplan-Meier survival 
curves of chow-fed Fabp4/5-/- (red) and WT (blue) mice (N = 40) for both sexes. 
Each data point represents one animal. B. Physical appearance of WT and 
Fabp4/5-/- mice. (C-E) Echocardiography studies of aged (30-month-old) WT (N = 
6 female / 8 male) and Fabp4/5-/- (N = 3 female / 8 male) mice. Left ventricle 
mass adjusted by body weight (C), ejection fraction (D), and end diastolic 
dimension (E). F. Grip strength test (WT, N = 25 female / 26 male); Fabp4/5-/-, N 
= 15 female / 20 male). Data were presented as mean ± SEM, and analyzed by 
Log-rank test, or unpaired Student’s t-Test, *P < 0.05, **P < 0.01, ***P < 0.001. 
See also Figure S4, Table S1 and Table S2. 
 
 
 
 
 Supplementary Figure 1 related to Figure 1. Middle-aged (11~12-month old) mice of both sexes were 
investigated for metabolic phenotypes (N = 7-8 female, N = 6 male). A. Insulin tolerance test. Open circle, 
WT; closed circle, Fabp4/5-/-. Areas under the curve (AUC) were plotted on the right. Late-middle-aged 
(15-month old) mice of both sexes (N = 8 female, N = 10 male) were investigated for metabolic phenotypes 
(B-D). B. Body weight. C. Intraperitoneal glucose tolerance test. D. Levels of blood glucose in male and 
female after 6-hour daytime food withdrawal. At 15-16 months of age, mice were placed on high-fat diet 
(HFD) for 8 months. Data were presented as mean ± SEM, and analyzed by unpaired two-way Student’s t- 
Test or post hoc Sidak’s multiple comparisons test, *p < 0.05, **p  < 0.01, ***p  < 0.001, ****p  < 0.0001.  
 
Supplementary Figure 2 related to Figure 2. A-B. Circulating levels of proinflammatory cytokines IL-6 
(A) and TNF (B) in middle-aged WT and Fabp4/5-/- mice (N = 6). C-E. Energy balance measurements by 
the Columbus Instruments Comprehensive Lab Animal Monitoring System (CLAMS) in middle-aged (12-
month old) mice (N = 4 per sex per genotype). C. Energy expenditure. D. Food intake. E. Respiratory 
exchange ratio (RER). Data were presented as mean ± SEM, and analyzed by unpaired two-way Student’s 
t-Test, *p < 0.05, **p < 0.01, ****p < 0.0001, n.d., not detected. 
  
 
 
 
 
Supplementary Figure 3 related to Figure 3. A. FABP secretion assay. Adipose tissue explants were 
dissected from short-term CR mice and ad libitum control mice (N = 6, upper panel: male mice; lower 
panel: female mice). CM, conditioned medium. CL, cell lysate. 12.5 µg of proteins isolated from tissue 
homogenates were loaded per lane. The load of CM samples was adjusted as conditioned from the load of 
CL. Secretion capacity is measured by the secretion index, which is the ratio of the density of CM sample 
over that of CL sample. B. Density analysis of Western blot graphs in Figure 3B (N = 3). C. Density 
analysis of lipogenic enzymes and FABP in adipose explants described in Panel A Upper Panel. D. 
Western blotting analysis of lipogenic transcription factors in subcutaneous adipose tissue from 4-week CR 
mice and ad libitum control mice (N = 3). Liver samples from 4-week AL mice served as positive control 
for Chrebpα and Srebp1c (precursor and cleaved forms). E. Western blotting analysis of epididymal 
adipose tissue from 3-4 month-old Fabp4/5-/- mice and WT mice (N = 5). F. Levels of phospholipids from 
epididymal white adipose tissue (WAT) and liver samples from calorie restricted (CR Aged) mice and ad 
libitum (AL Aged) control mice were analyzed by lipidomics (N = 6). Data were presented as mean ± SEM, 
and analyzed by multiple comparison t-Test adjusted by Holm-Sidak method (Panels B, D), and unpaired 
two-way Student’s t-Test (Panels A, C, F), n.s., not significant, *p < 0.05, **p < 0.01, ***p < 0.001. 
 Supplementary Figure 4 related to Figure 4. A. Serum levels of IGF-1 in middle-aged (12-month-old) 
WT (N = 4 female / 5 male) and Fabp4/5-/- (N = 4 female / 5 male). B. Kaplan-Meier survival curves of 
HFD-fed Fabp4/5-/- and WT mice (N = 8-10) for both sexes. Each data point represents one animal. At 15-
16 months of age, mice were placed on high-fat diet (HFD) for 8 months. Survival after initiation of HFD 
WT male = 40%; Fabp4/5-/- male = 30%; WT female = 60%; Fabp4/5-/- female = 60%. C-D. Healthspan 
studies of chow-fed aged (30-month-old) mice: (C) Cognitive functions: Y-maze test (WT, N = 24 male 
and 24 female; Fabp4/5-/-, N = 18 male and 14 female). (D) Anti-depressant function: Tail suspension test 
(WT, N = 24 male and 17 female; Fabp4/5-/-, N = 15 male and 8 female). Data were presented as mean ± 
SEM, and analyzed by unpaired two-way Student’s t-Test, *p < 0.05, **p < 0.01. 
Supplementary Table 1. Gait analysis of aged (30-month-old) female mice, Related to Figure 4 
 
  WT (N = 24) Fabp4/5-/- (N = 14) P value 
Belt Speed (cm/s) 11.8 ± 0.1 11.1 ± 0.6 0.12 
Stride Length (mm) (FF AVG) 54.20 ± 0.60 54.19 ± 1.80 0.21 
Stride Length (mm) (RF AVG) 54.91 ± 0.51 53.22 ± 1.72 0.26 
Rear Stance Width (mm) 28.02 ± 0.26 27.32 ± 0.58 0.22 
Homolateral Coupling (RR) 0.44 ± 0.01 0.42 ± 0.02 0.23 
Homologous Coupling (RR) 0.49 ± 0.01 0.51 ± 0.01 0.10 
Diagonal Coupling (RR) -0.03 ± 0.01 -0.07 ± 0.02 0.05 
Print Angle (deg) (RR) 25.06 ± 1.58 23.49 ± 2.32 0.57 
    Data presented are mean ± SEM.  
    
 
 
Supplementary Table 2. Gait analysis of aged (30-month-old) male mice, Related to Figure 4 
 
  WT (N = 25) Fabp4/5-/- (N = 19) P value 
Belt Speed (cm/s) 12.0 ± 0.1 10.6 ± 0.6 * 0.01 
Stride Length (mm) (FF AVG) 53.80 ± 0.74 54.55 ± 1.72 0.66 
Stride Length (mm) (RF AVG) 54.74 ± 0.75 55.86 ± 1.68 0.51 
Rear Stance Width (mm) 26.82 ± 0.30 26.39 ± 0.48 0.43 
Homolateral Coupling (RR) 0.41 ± 0.01 0.41 ± 0.02 0.94 
Homologous Coupling (RR) 0.50 ± 0.01 0.49 ± 0.02 0.53 
Diagonal Coupling (RR) -0.07 ± 0.01 -0.07 ± 0.02 0.98 
Print Angle (deg) (RR) 26.68 ± 1.79 27.83 ± 2.20 0.76 
    Data presented are mean ± SEM.  
    
Supplementary Table 3. Primer Sequences, Related to Experimental Procedures 
Name DNA Sequence 
36B4-Forward (F) CCGATCTGCAGACACACACT 
36B4-Reverse (R) ACCCTGAAGTGCTCGACATC 
Acas2-F GCTGAACTGACACACCTGGA 
Acas2-R AACTTGGCGACAAAGTTGCT 
Acly-F AATGGCCGTCATGTGAGTTT 
Acly-R GTGGCCCCAACTATCAAGAG 
Acc-F GAAGCCACAGTGAAATCTCG 
Acc-R GATGGTTTGGCCTTTCACAT 
Fasn-F GTTGGCCCAGAACTCCTGTA 
Fasn-R GTCGTCTGCCTCCAGAGC 
Elovl6-F AACTTGGCTCGCTTGTTCAT 
Elovl6-R CCAATGGATGCAGGAAAACT 
Scd1-F CAGCCGAGCCTTGTAAGTTC 
Scd1-R GCTCTACACCTGCCTCTTCG 
 




